PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot study-Reference-Cited by-同舟云学术

PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot study

Published:2021-11 Issue:6 Volume:20 Page:1090-1098
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Reynaud Thomas^ORCID,Hathout Lara,Carignan Damien,Barkati Maroie^ORCID,Martin André-Guy^ORCID,Foster William^ORCID,Lacroix Frédéric,Delouya Guila,Taussky Daniel^ORCID,Morton Gerard^ORCID,Vigneault Eric

Funder

Canadian Association of Radiation Oncology

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference54 articles.

1. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D'Amico;JAMA,1998

2. Brachytherapy provides comparable outcomes and improved cost-effectiveness in the treatment of low/intermediate prostate cancer;Shah;Brachytherapy,2012

3. A critical analysis of the long-term impact of brachytherapy for prostate cancer: a review of the recent literature;Bowes;Curr Opin Urol,2011

4. Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy;Hinnen;Int J Radiat Oncol Biol Phys,2010

5. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation;Zelefsky;Int J Radiat Oncol Biol Phys,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population‐based patient‐reported quality of life outcomes following low‐dose‐rate versus high‐dose‐rate brachytherapy monotherapy for low‐intermediate risk prostate cancer;Journal of Medical Imaging and Radiation Oncology;2023-10

2. Global research status and hotspots of radiotherapy for prostate cancer: a bibliometric analysis based on Web of Science from 2010-2022;Frontiers in Oncology;2023-08-11

3. Function Preservation with Brachytherapy: Reviving the Art;Clinical Oncology;2023-08

4. LDR brachytherapy offers superior tumor control to single‐fraction HDR prostate brachytherapy: A prospective study;The Prostate;2023-05-07

5. Safety and efficacy associated with single-fraction high-dose-rate brachytherapy in localized prostate cancer: a systematic review and meta-analysis;Strahlentherapie und Onkologie;2023-04-24